{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:34:33Z","timestamp":1773322473129,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:00:00Z","timestamp":1518220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:00:00Z","timestamp":1518220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK103842; DK066557; DK66667; DK66568;DK66471; DK66"],"award-info":[{"award-number":["DK103842; DK066557; DK66667; DK66568;DK66471; DK66"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00125-018-4553-y","type":"journal-article","created":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T12:45:48Z","timestamp":1518266748000},"page":"1142-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2\u00a0years after Roux-en-Y gastric bypass"],"prefix":"10.1007","volume":"61","author":[{"given":"Jonathan Q.","family":"Purnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdus S.","family":"Wahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Dalla Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Piccinini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Prigeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bret H.","family":"Goodpaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrlene A.","family":"Staten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Foster-Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Flum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita P.","family":"Courcoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Havel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"key":"4553_CR1","doi-asserted-by":"publisher","first-page":"582S","DOI":"10.1093\/ajcn\/55.2.582s","volume":"55","author":"WJ Pories","year":"1992","unstructured":"Pories WJ, MacDonald KG Jr, Morgan EJ et al (1992) Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 55:582S\u2013585S","journal-title":"Am J Clin Nutr"},{"key":"4553_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2337\/dc15-2138","volume":"39","author":"JQ Purnell","year":"2016","unstructured":"Purnell JQ, Selzer F, Wahed AS et al (2016) Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the Longitudinal Assessment of Bariatric Surgery Study. Diabetes Care 39:1101\u20131107","journal-title":"Diabetes Care"},{"key":"4553_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1056\/NEJMoa1600869","volume":"376","author":"PR Schauer","year":"2017","unstructured":"Schauer PR, Bhatt DL, Kirwan JP et al (2017) Bariatric surgery versus intensive medical therapy for diabetes -- 5-year outcomes. N Engl J Med 376:641\u2013651","journal-title":"N Engl J Med"},{"key":"4553_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11605-009-1060-y","volume":"14","author":"GM Campos","year":"2010","unstructured":"Campos GM, Rabl C, Peeva S et al (2010) Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 14:15\u201323","journal-title":"J Gastrointest Surg"},{"key":"4553_CR5","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1172\/JCI64895","volume":"122","author":"D Bradley","year":"2012","unstructured":"Bradley D, Conte C, Mittendorfer B et al (2012) Gastric bypass and banding equally improve insulin sensitivity and beta cell function. J Clin Invest 122:4667\u20134674","journal-title":"J Clin Invest"},{"key":"4553_CR6","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.2337\/db13-0321","volume":"62","author":"S Camastra","year":"2013","unstructured":"Camastra S, Muscelli E, Gastaldelli A et al (2013) Long-term effects of bariatric surgery on meal disposal and \u03b2-cell function in diabetic and nondiabetic patients. Diabetes 62:3709\u20133717","journal-title":"Diabetes"},{"key":"4553_CR7","first-page":"4047","volume":"86","author":"SE Kahn","year":"2001","unstructured":"Kahn SE (2001) The importance of \u03b2-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047\u20134058","journal-title":"J Clin Endocrinol Metab"},{"key":"4553_CR8","first-page":"2416","volume":"310","author":"AP Courcoulas","year":"2013","unstructured":"Courcoulas AP, Christian NJ, Belle SH et al (2013) Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 310:2416\u20132425","journal-title":"JAMA"},{"key":"4553_CR9","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2337\/dc14-0396","volume":"37","author":"PA Halban","year":"2014","unstructured":"Halban PA, Polonsky KS, Bowden DW et al (2014) \u03b2-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care 37:1751\u20131758","journal-title":"Diabetes Care"},{"key":"4553_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.soard.2007.01.006","volume":"3","author":"SH Belle","year":"2007","unstructured":"Belle SH, Berk PD, Courcoulas AP et al (2007) Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. Surg Obes Relat Dis 3:116\u2013126","journal-title":"Surg Obes Relat Dis"},{"key":"4553_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJMoa0901836","volume":"361","author":"Longitudinal Assessment of Bariatric Surgery Consortium","year":"2009","unstructured":"Longitudinal Assessment of Bariatric Surgery Consortium (2009) Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 361:445\u2013454","journal-title":"N Engl J Med"},{"key":"4553_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1172\/JCI118441","volume":"97","author":"RL Prigeon","year":"1996","unstructured":"Prigeon RL, Roder ME, Porte D Jr, Kahn SE (1996) The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest 97:501\u2013507","journal-title":"J Clin Invest"},{"key":"4553_CR13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2337\/dc09-9036","volume":"32","author":"JB Buse","year":"2009","unstructured":"Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133\u20132135","journal-title":"Diabetes Care"},{"key":"4553_CR14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2337\/db13-1198","volume":"63","author":"C Cobelli","year":"2014","unstructured":"Cobelli C, Dalla Man C, Toffolo G, Basu R, Vella A, Rizza R (2014) The oral minimal model method. Diabetes 63:1203\u20131213","journal-title":"Diabetes"},{"key":"4553_CR15","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","volume":"42","author":"SE Kahn","year":"1993","unstructured":"Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and \u03b2-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663\u20131672","journal-title":"Diabetes"},{"key":"4553_CR16","doi-asserted-by":"publisher","first-page":"E557","DOI":"10.1152\/ajpendo.00325.2002","volume":"284","author":"M Guldstrand","year":"2003","unstructured":"Guldstrand M, Ahren B, Adamson U (2003) Improved \u03b2-cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 284:E557\u2013E565","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4553_CR17","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2337\/db06-0068","volume":"55","author":"C Guidone","year":"2006","unstructured":"Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025\u20132031","journal-title":"Diabetes"},{"key":"4553_CR18","first-page":"235","volume":"92","author":"JD Halverson","year":"1982","unstructured":"Halverson JD, Kramer J, Cave A, Permutt A, Santiago J (1982) Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery 92:235\u2013240","journal-title":"Surgery"},{"key":"4553_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/01.sla.0000183349.16877.84","volume":"243","author":"CW le Roux","year":"2006","unstructured":"le Roux CW, Aylwin SJ, Batterham RL et al (2006) Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108\u2013114","journal-title":"Ann Surg"},{"key":"4553_CR20","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1464-5491.2007.02240.x","volume":"24","author":"HE Johansson","year":"2007","unstructured":"Johansson HE, Ohrvall M, Haenni A et al (2007) Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion. Diabet Med 24:1213\u20131220","journal-title":"Diabet Med"},{"key":"4553_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/oby.2007.83","volume":"16","author":"F Rodieux","year":"2008","unstructured":"Rodieux F, Giusti V, D\u2019Alessio DA, Suter M, Tappy L (2008) Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 16:298\u2013305","journal-title":"Obesity (Silver Spring)"},{"key":"4553_CR22","doi-asserted-by":"publisher","first-page":"E504","DOI":"10.1152\/ajpendo.00099.2005","volume":"289","author":"R Chaikomin","year":"2005","unstructured":"Chaikomin R, Doran S, Jones KL et al (2005) Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 289:E504\u2013E507","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4553_CR23","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s11695-012-0656-6","volume":"22","author":"G Wang","year":"2012","unstructured":"Wang G, Agenor K, Pizot J et al (2012) Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP). Obes Surg 22:1263\u20131267","journal-title":"Obes Surg"},{"key":"4553_CR24","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1001\/jama.2010.785","volume":"303","author":"IB Hirsch","year":"2010","unstructured":"Hirsch IB, Brownlee M (2010) Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications. JAMA 303:2291\u20132292","journal-title":"JAMA"},{"key":"4553_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa066603","volume":"357","author":"TD Adams","year":"2007","unstructured":"Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753\u2013761","journal-title":"N Engl J Med"},{"key":"4553_CR26","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1001\/jama.2014.5988","volume":"311","author":"L Sjostrom","year":"2014","unstructured":"Sjostrom L, Peltonen M, Jacobson P et al (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311:2297\u20132304","journal-title":"JAMA"},{"key":"4553_CR27","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2337\/dc06-1549","volume":"30","author":"B Laferrere","year":"2007","unstructured":"Laferrere B, Heshka S, Wang K et al (2007) Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30:1709\u20131716","journal-title":"Diabetes Care"},{"key":"4553_CR28","doi-asserted-by":"crossref","unstructured":"Korner J, Inabnet W, Febres G et al (2009) Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 33:786\u2013795","DOI":"10.1038\/ijo.2009.79"},{"key":"4553_CR29","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.2337\/db11-0203","volume":"60","author":"M Salehi","year":"2011","unstructured":"Salehi M, Prigeon RL, D\u2019Alessio DA (2011) Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 60:2308\u20132314","journal-title":"Diabetes"},{"key":"4553_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2337\/dc11-1472","volume":"35","author":"BJ Van der Schueren","year":"2012","unstructured":"Van der Schueren BJ, Homel P, Alam M et al (2012) Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery. Diabetes Care 35:42\u201346","journal-title":"Diabetes Care"},{"key":"4553_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1172\/JCI116186","volume":"91","author":"MA Nauck","year":"1993","unstructured":"Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301\u2013307","journal-title":"J Clin Invest"},{"key":"4553_CR32","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2337\/db09-1414","volume":"59","author":"KJ Hare","year":"2010","unstructured":"Hare KJ, Vilsboll T, Asmar M, Deacon CF, Knop FK, Holst JJ (2010) The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action. Diabetes 59:1765\u20131770","journal-title":"Diabetes"},{"key":"4553_CR33","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1210\/jc.2007-0918","volume":"92","author":"AB Goldfine","year":"2007","unstructured":"Goldfine AB, Mun EC, Devine E et al (2007) Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 92:4678\u20134685","journal-title":"J Clin Endocrinol Metab"},{"key":"4553_CR34","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1210\/jc.2013-2538","volume":"98","author":"M Nannipieri","year":"2013","unstructured":"Nannipieri M, Baldi S, Mari A et al (2013) Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 98:4391\u20134399","journal-title":"J Clin Endocrinol Metab"},{"key":"4553_CR35","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1210\/jc.2013-2686","volume":"99","author":"M Salehi","year":"2014","unstructured":"Salehi M, Gastaldelli A, D\u2019Alessio DA (2014) Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab 99:2008\u20132017","journal-title":"J Clin Endocrinol Metab"},{"key":"4553_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soard.2013.07.010","volume":"10","author":"GM Campos","year":"2014","unstructured":"Campos GM, Rabl C, Havel PJ et al (2014) Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery. Surg Obes Relat Dis 10:1\u20138","journal-title":"Surg Obes Relat Dis"},{"key":"4553_CR37","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2337\/db14-0242","volume":"63","author":"J Cegla","year":"2014","unstructured":"Cegla J, Troke RC, Jones B et al (2014) Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake. Diabetes 63:3711\u20133720","journal-title":"Diabetes"},{"key":"4553_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2337\/diabetes.52.5.1098","volume":"52","author":"EV Polyzogopoulou","year":"2003","unstructured":"Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK (2003) Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 52:1098\u20131103","journal-title":"Diabetes"},{"key":"4553_CR39","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1136\/bmj.1.6020.1252","volume":"1","author":"RC Turner","year":"1976","unstructured":"Turner RC, McCarthy ST, Holman RR, Harris E (1976) Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Br Med J 1:1252\u20131254","journal-title":"Br Med J"},{"key":"4553_CR40","doi-asserted-by":"publisher","first-page":"E1372","DOI":"10.1210\/jc.2011-0446","volume":"96","author":"M Nannipieri","year":"2011","unstructured":"Nannipieri M, Mari A, Anselmino M et al (2011) The role of \u03b2-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 96:E1372\u2013E1379","journal-title":"J Clin Endocrinol Metab"},{"key":"4553_CR41","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1113\/JP270264","volume":"593","author":"MT Lund","year":"2015","unstructured":"Lund MT, Hansen M, Skaaby S et al (2015) Preoperative \u03b2-cell function in patients with type 2 diabetes is important for the outcome of roux-en-Y gastric bypass surgery. J Physiol 593:3123\u20133133","journal-title":"J Physiol"},{"key":"4553_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2337\/dc08-1314","volume":"32","author":"S Salinari","year":"2009","unstructured":"Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G (2009) First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 32:375\u2013380","journal-title":"Diabetes Care"},{"key":"4553_CR43","doi-asserted-by":"publisher","first-page":"E535","DOI":"10.1152\/ajpendo.00506.2014","volume":"308","author":"C Martinussen","year":"2015","unstructured":"Martinussen C, Bojsen-Moller KN, Dirksen C et al (2015) Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass. Am J Physiol Endocrinol Metab 308:E535\u2013E544","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4553_CR44","doi-asserted-by":"publisher","first-page":"E122","DOI":"10.1152\/ajpendo.00073.2012","volume":"303","author":"NB Jorgensen","year":"2012","unstructured":"Jorgensen NB, Jacobsen SH, Dirksen C et al (2012) Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 303:E122\u2013E131","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4553_CR45","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00125-011-2193-6","volume":"54","author":"S Camastra","year":"2011","unstructured":"Camastra S, Gastaldelli A, Mari A et al (2011) Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 54:2093\u20132102","journal-title":"Diabetologia"},{"key":"4553_CR46","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2337\/db13-1176","volume":"63","author":"R Dutia","year":"2014","unstructured":"Dutia R, Brakoniecki K, Bunker P et al (2014) Limited recovery of \u03b2-cell function after gastric bypass despite clinical diabetes remission. Diabetes 63:1214\u20131223","journal-title":"Diabetes"},{"key":"4553_CR47","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.2337\/diabetes.54.11.3265","volume":"54","author":"C Dalla Man","year":"2005","unstructured":"Dalla Man C, Campioni M, Polonsky KS et al (2005) Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of \u03b2-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54:3265\u20133273","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4553-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T17:36:24Z","timestamp":1589564184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4553-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,10]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4553"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4553-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,10]]},"assertion":[{"value":"12 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JQP receives consultant income for services on an advisory board for Novo Nordisk and receives grant funding from the NIH. CC holds ten patents and patent applications related to glucose sensors and artificial pancreas, received non-financial support from Roche and Dexcom, Inc., research support from Dexcom, Inc., Sanofi Aventis and Adocia and consultant income for services on an advisory board for Novo Nordisk. From 2007\u20132017, DEK was a full-time employee of Merck & Co. Inc., receiving salary and stock, but is now retired. DEC receives research support from Johnson & Johnson, the NIH and Medtronic. DRF receives consulting fees from Pacira Pharm and Patient Centered outcomes with Surgical Consulting LLC. APC receives grant support from the NIH and Covidien\/Ethicon J&J. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}